Skip to main content
Top
Published in: World Journal of Surgery 7/2005

01-07-2005 | Original Scientific Reports

Prediction of Metastasis to Non-sentinel Nodes by Sentinel Node Status and Primary Tumor Characteristics in Primary Breast Cancer in Taiwan

Authors: Jyh-Cherng Yu, M.D., Giu-Cheng Hsu, M.D., Chung-Bo Hsieh, M.D., Lai-Fa Sheu, M.D., Ph.D., Tsu-Yi Chao, M.D., PhD.

Published in: World Journal of Surgery | Issue 7/2005

Login to get access

Abstract

We aimed to determine how to approach the axilla after finding a positive sentinel node (SN) for a woman with breast cancer in Taiwan. We used blue dye staining to identify the SN in 824 procedures on 811 patients with breast cancer small than 3 cm by a single surgeon. All patients underwent SN biopsy, followed by at least level II axillary dissection. All SNs were evaluated histologically and immunohistochemically with anti-cytokeratin antibodies. Non-SNs were examined by routine histology. SNs were identified in 814/824 procedures (98.8%). SN metastases were found in 286/814 (35.1%). Subsequent axillary dissections revealed tumors in non-SNs in 188 (65.7%) of these patients. There was a relatively high incidence of non-SN metastases in our population. Tumor exhibiting high nuclear grading, ER-, PR-, Erb-2/neu overexpression, lymphovascular invasion, increasing tumor size, multiple positive SNs, and macrometastatic size in SNs (> 2 mm) were all significantly correlated with non-SN metastases. Multivariate analysis showed that tumor size, the number of positive SNs, and the metastatic size in SNs were independent factors predicting the presence of positive non-SNs. Small (< 2 cm) cancers, having only micrometastatic foci in the SN and having only one SN involved are closely correlated with the tumor-free non-SNs. Our data will assist such patients regarding the need for axillary dissection after finding a positive SN.
Literature
1.
go back to reference Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg. Oncol. 1993;2:335–340CrossRefPubMed Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg. Oncol. 1993;2:335–340CrossRefPubMed
2.
go back to reference Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann. Surg. 1994;220:391–401PubMed Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann. Surg. 1994;220:391–401PubMed
3.
go back to reference Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. J.A.M.A. 1996;276:1818–1822PubMedCrossRef Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. J.A.M.A. 1996;276:1818–1822PubMedCrossRef
4.
go back to reference Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J. Clin. Oncol. 1997;15:2345–2350PubMed Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J. Clin. Oncol. 1997;15:2345–2350PubMed
5.
go back to reference Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864–1867CrossRefPubMed Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864–1867CrossRefPubMed
6.
go back to reference Yu JC, Hsu GC, Liu YC, et al. Sentinel node biopsy in early breast cancer in Taiwan. World J. Surg. 2002;26:1365–1369CrossRefPubMed Yu JC, Hsu GC, Liu YC, et al. Sentinel node biopsy in early breast cancer in Taiwan. World J. Surg. 2002;26:1365–1369CrossRefPubMed
7.
go back to reference Chu KU, Turner RR, Hansen NM, et al. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann. Surg. 1999;229:536–541 Chu KU, Turner RR, Hansen NM, et al. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann. Surg. 1999;229:536–541
8.
go back to reference Wong SL, Edward MJ, Chao C, et al. Predicting the status of the nonsentinel axillary nodes. Arch. Surg. 2001;136:563–568CrossRefPubMed Wong SL, Edward MJ, Chao C, et al. Predicting the status of the nonsentinel axillary nodes. Arch. Surg. 2001;136:563–568CrossRefPubMed
9.
go back to reference Rahusen FD, Torrenga H, Diest PJ, et al. Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch. Surg. 2001;136:1059–1063CrossRefPubMed Rahusen FD, Torrenga H, Diest PJ, et al. Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch. Surg. 2001;136:1059–1063CrossRefPubMed
10.
go back to reference Reynolds C, Mick R, Donohue JH, et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer. J. Clin. Oncol. 1999;17:1720–1726PubMed Reynolds C, Mick R, Donohue JH, et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer. J. Clin. Oncol. 1999;17:1720–1726PubMed
11.
go back to reference Weiser MR, Montgomery LL, Tan LK, et al. Lymphovascular invasion enhances the prediction of nonsentinel node metastases in breast cancer patients with positive sentinel node. Ann. Surg. Oncol. 2001;8:145–149PubMed Weiser MR, Montgomery LL, Tan LK, et al. Lymphovascular invasion enhances the prediction of nonsentinel node metastases in breast cancer patients with positive sentinel node. Ann. Surg. Oncol. 2001;8:145–149PubMed
12.
go back to reference Bakker MA, Weeszenberg A, Kanter AY, et al. Nonsentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance. J. Clin. Pathol. 2002;55:932–935CrossRef Bakker MA, Weeszenberg A, Kanter AY, et al. Nonsentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance. J. Clin. Pathol. 2002;55:932–935CrossRef
13.
go back to reference Guenther JM, Hansen NM, DiFronzon LA, et al. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch. Surg. 2003;138:52–56PubMed Guenther JM, Hansen NM, DiFronzon LA, et al. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch. Surg. 2003;138:52–56PubMed
14.
go back to reference Sachdev U, Murphy K, Derzie A, et al. Predictors of nonsentinel lymph node metastasis in breast cancer patients. Ann. J. Surg. 2002;183:213–217CrossRef Sachdev U, Murphy K, Derzie A, et al. Predictors of nonsentinel lymph node metastasis in breast cancer patients. Ann. J. Surg. 2002;183:213–217CrossRef
15.
go back to reference Hwang RF, Krishnamurthy S, Hunt KK, et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann. Surg. Oncol. 2003;10:248–254CrossRefPubMed Hwang RF, Krishnamurthy S, Hunt KK, et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann. Surg. Oncol. 2003;10:248–254CrossRefPubMed
16.
go back to reference Travagli JP, Atallah D, Mathiru MC, et al. Sentinel lymphadenectomy without systemic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis. Eur. J. Surg. Oncol. 2003;29:403–406CrossRefPubMed Travagli JP, Atallah D, Mathiru MC, et al. Sentinel lymphadenectomy without systemic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis. Eur. J. Surg. Oncol. 2003;29:403–406CrossRefPubMed
17.
go back to reference Lo YL, Yu JC, Huang CS, et al. Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset). Int. J. Cancer 1998;79:580–587CrossRefPubMed Lo YL, Yu JC, Huang CS, et al. Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset). Int. J. Cancer 1998;79:580–587CrossRefPubMed
18.
go back to reference Cheng SH, Tsou MH, Liu MC, et al. Unique features of breast cancer in Taiwan. Breast Cancer Res. Treat. 2000;63:213–223CrossRefPubMed Cheng SH, Tsou MH, Liu MC, et al. Unique features of breast cancer in Taiwan. Breast Cancer Res. Treat. 2000;63:213–223CrossRefPubMed
19.
go back to reference Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 1997;349:1668–1669CrossRefPubMed Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 1997;349:1668–1669CrossRefPubMed
20.
go back to reference Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J. Am. Coll. Surg. 1998;186:275–283CrossRefPubMed Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J. Am. Coll. Surg. 1998;186:275–283CrossRefPubMed
21.
go back to reference Flett MM, Going JJ, Stanton PD, et al. Sentinel node localization in patients with breast cancer. Br. J. Surg. 1998;85:991–993CrossRefPubMed Flett MM, Going JJ, Stanton PD, et al. Sentinel node localization in patients with breast cancer. Br. J. Surg. 1998;85:991–993CrossRefPubMed
22.
go back to reference Offodile R, Hoh C, Barsky SH, et al. Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled Dextran. Cancer 1998;82:1704–1708CrossRefPubMed Offodile R, Hoh C, Barsky SH, et al. Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled Dextran. Cancer 1998;82:1704–1708CrossRefPubMed
23.
go back to reference Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann. Surg. 1999;227:645–653CrossRefPubMed Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann. Surg. 1999;227:645–653CrossRefPubMed
24.
go back to reference Motomura K, Inaji H, Komoike Y, et al. Sentinel node biopsy guided by indocyanine green dye in breast cancer patients. Jpn. J. Clin. Oncol. 1999;29:604–607CrossRefPubMed Motomura K, Inaji H, Komoike Y, et al. Sentinel node biopsy guided by indocyanine green dye in breast cancer patients. Jpn. J. Clin. Oncol. 1999;29:604–607CrossRefPubMed
25.
go back to reference Simmons RM, Thevarajah S, Brennan MB, et al. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Ann. Surg. Oncol. 2003;10:242–247CrossRefPubMed Simmons RM, Thevarajah S, Brennan MB, et al. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Ann. Surg. Oncol. 2003;10:242–247CrossRefPubMed
26.
go back to reference Blessing WD, Stolier AJ, Teng SC, et al. A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping. Ann. J. Surg. 2002;184:341–345CrossRef Blessing WD, Stolier AJ, Teng SC, et al. A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping. Ann. J. Surg. 2002;184:341–345CrossRef
27.
go back to reference Schreiber RH, Pendas S, Ku NN, et al. Microstaging of breast cancer patients using cytokeratin staging of the sentinel lymph node. Ann. Surg. Oncol. 1999;6:95–101CrossRefPubMed Schreiber RH, Pendas S, Ku NN, et al. Microstaging of breast cancer patients using cytokeratin staging of the sentinel lymph node. Ann. Surg. Oncol. 1999;6:95–101CrossRefPubMed
28.
go back to reference Pargaonkar AS, Beissner RS, Snyder S, et al. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer. Arch. Pathol. Lab. Med. 2003;127:701–705PubMed Pargaonkar AS, Beissner RS, Snyder S, et al. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer. Arch. Pathol. Lab. Med. 2003;127:701–705PubMed
29.
go back to reference Chu KU, Turner RR, Hansen NM, et al. Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis. Ann. Surg. Oncol. 1999;6:756–761CrossRefPubMed Chu KU, Turner RR, Hansen NM, et al. Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis. Ann. Surg. Oncol. 1999;6:756–761CrossRefPubMed
30.
go back to reference Clare SE, Sener SF, Wilkens W, et al. Prognostic significance of occult lymph node metastasis in node-negative breast cancer. Ann. Surg. Oncol. 1991;4:447–451CrossRef Clare SE, Sener SF, Wilkens W, et al. Prognostic significance of occult lymph node metastasis in node-negative breast cancer. Ann. Surg. Oncol. 1991;4:447–451CrossRef
31.
go back to reference Cox CE. Clinical relevance of serial sectioning of sentinel nodes and the detection of micrometastatic nodal disease in breast cancer. Ann. Surg. Oncol. 1997;5:297–298CrossRef Cox CE. Clinical relevance of serial sectioning of sentinel nodes and the detection of micrometastatic nodal disease in breast cancer. Ann. Surg. Oncol. 1997;5:297–298CrossRef
32.
go back to reference Czerniecki BJ, Scheff AM, Callans LS, et al. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 1999;85:1098–1103CrossRefPubMed Czerniecki BJ, Scheff AM, Callans LS, et al. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 1999;85:1098–1103CrossRefPubMed
33.
go back to reference Cohen C, Alazraki N, Styblo T, et al. Immunohistochemical evaluation of sentinel lymph nodes in breast carcinoma patients. Appl. Immunohistochem. Mol. Morphol. 2002;10:296–303CrossRefPubMed Cohen C, Alazraki N, Styblo T, et al. Immunohistochemical evaluation of sentinel lymph nodes in breast carcinoma patients. Appl. Immunohistochem. Mol. Morphol. 2002;10:296–303CrossRefPubMed
34.
go back to reference Noguchi M. Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodes. Br. J. Surg. 2002;89:1505–1515CrossRefPubMed Noguchi M. Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodes. Br. J. Surg. 2002;89:1505–1515CrossRefPubMed
35.
go back to reference Motomura K, Komoike Y, Inaji H, et al. Multiple sectioning and immunohistochemical staining of sentinel nodes in patients with breast cancer. Br. J. Surg. 2002;89:1032–1034CrossRefPubMed Motomura K, Komoike Y, Inaji H, et al. Multiple sectioning and immunohistochemical staining of sentinel nodes in patients with breast cancer. Br. J. Surg. 2002;89:1032–1034CrossRefPubMed
36.
go back to reference Turner RR, Giuliano AE, Hoon DS, et al. Pathologic examination of sentinel lymph node for breast carcinoma. World J. Surg. 2001;25:798–805CrossRefPubMed Turner RR, Giuliano AE, Hoon DS, et al. Pathologic examination of sentinel lymph node for breast carcinoma. World J. Surg. 2001;25:798–805CrossRefPubMed
Metadata
Title
Prediction of Metastasis to Non-sentinel Nodes by Sentinel Node Status and Primary Tumor Characteristics in Primary Breast Cancer in Taiwan
Authors
Jyh-Cherng Yu, M.D.
Giu-Cheng Hsu, M.D.
Chung-Bo Hsieh, M.D.
Lai-Fa Sheu, M.D., Ph.D.
Tsu-Yi Chao, M.D., PhD.
Publication date
01-07-2005
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 7/2005
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-005-7744-x

Other articles of this Issue 7/2005

World Journal of Surgery 7/2005 Go to the issue

Letters to the Editor

To the Editor